Skip to content

Biodesix, Inc. BDSX Common Stock

Common Stock at other companies

NeoGenomics logo
NeoGenomicsNEO
$129K+0.8%
Veracyte logo
VeracyteVCYT
125M0.0%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$16K+6.7%
Personalis, Inc. logo
Personalis, Inc.PSNL
$10K+11.1%
Guardant Health logo
Guardant HealthGH
$1K0.0%
GeneDx Holdings logo
GeneDx HoldingsWGS
1B0.0%

Other financials

Income statement

See full
Revenue$25.6M+42.3%
Operating income-$6.2M+32.1%
Net income-$7.8M+29.8%
EPS (diluted)-$0.81+46.7%

Balance sheet

See full
Cash & equivalents$25.6M+45.3%
Total debt$71.6M+15.0%
Total equity$9.1M-17.4%
Total assets$94.6M+9.7%

Cash flow

See full
Operating cash flow-$10.2M-18.2%
CapEx$81.0K+9.5%
Free cash flow-$10.2M-18.1%

Valuation

See full
Market cap$233.52M+462%
Enterprise value$279.56M+198%
P/S2.4×+1.9×

Profitability

See full
Operating margin-26%-7.5pp
Net margin-33.3%-9.3pp
FCF margin-26.8%-9.6pp

Returns & leverage

See full
Return on equity-316.5%
Debt / equity7.8×+2.2×
Current ratio2.8×+0.6×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biodesix, Inc.'s common stock?
Biodesix, Inc. (BDSX) reported common stock of $10K in Q1 2026.
How has Biodesix, Inc.'s common stock changed year-over-year?
Biodesix, Inc.'s common stock decreased by 93.2% year-over-year, from $146K to $10K.
What is the long-term trend for Biodesix, Inc.'s common stock?
Over 5 years (2020 to 2025), Biodesix, Inc.'s common stock has grown at a -21.6% compound annual growth rate (CAGR), from $27K to $8K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).